Loading…
avatar for Greg Ball

Greg Ball

Merck & Co., Inc.
Senior Principal Biostatistician
Dr. Greg Ball’s current research on blinded safety monitoring procedures emerged from his early work at academic medical centers and CROs, developed into his college dissertation and continues to be developed in collaboration with statistical and clinical scientists from several pharmaceutical companies. He is a co-lead for the ASA Safety Monitoring working group, focusing on safety regulations and cross-disciplinary scientific engagement.